ICM
LAZ icon

Invenomic Capital Management’s Lazard LAZ Stock Holding History

Invenomic Capital Management’s Portfolio LAZ Stock Details LAZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-256,750
Closed -$10.9M – 136
2026
Q1 		$10.9M Buy
+256,750
New +$12.6M 0.5% 65
2024
Q1 		– Sell
-435,298
Closed -$15.1M – 170
2023
Q4 		$15.1M Sell
435,298
-181,683
-29% -$5.47M 0.69% 48
2023
Q3 		$19.1M Sell
616,981
-51,698
-8% -$1.73M 0.8% 39
2023
Q2 		$21.4M Buy
668,679
+329,631
+97% +$10.2M 1.08% 34
2023
Q1 		$11.2M Buy
+339,048
New +$12.5M 0.63% 52
2022
Q3 		– Sell
-171,322
Closed -$5.55M – 169
2022
Q2 		$5.55M Buy
+171,322
New +$5.78M 0.39% 76
2021
Q4 		– Sell
-24,767
Closed -$1.13M – 154
2021
Q3 		$1.13M Sell
24,767
-46,928
-65% -$2.19M 0.37% 83
2021
Q2 		$3.24M Sell
71,695
-1,457
-2% -$66.8K 0.78% 28
2021
Q1 		$3.18M Buy
73,152
+58,209
+390% +$2.48M 0.71% 29
2020
Q4 		$632K Sell
14,943
-13,689
-48% -$517K 0.16% 90
2020
Q3 		$947K Sell
28,632
-3,052
-10% -$94K 0.52% 62
2020
Q2 		$907K Buy
31,684
+8,127
+34% +$220K 0.67% 52
2020
Q1 		$555K Buy
+23,557
New +$872K 0.45% 66

Other funds holding LAZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invenomic Capital Management's LAZ Position: Q2 2026 in Review

Invenomic Capital Management sold out of Lazard (LAZ) in Q2 2026, closing a stake of 256,750 shares — an estimated $10.9M sold.

Invenomic Capital Management first reported a position in LAZ in Q1 2020 and held it in 13 quarters. The position peaked at $21.4M in Q2 2023. 344 funds tracked by Wall St. Rank hold LAZ as of Q2 2026.

  • Invenomic Capital Management reported no remaining Lazard position as of Q2 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 256,750 Lazard shares in Q2 2026, an estimated $10.9M.
  • Invenomic Capital Management first reported a position in Lazard in Q1 2020 and held it in 13 quarters.
  • Invenomic Capital Management's Lazard position peaked at $21.4M in Q2 2023.
  • 344 funds tracked by Wall St. Rank held Lazard as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.